← Back to XBIO

Xenetic Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 13/05/2025
$0.7$0.8$1$0.6$0.6$0.6$0.7$0.5
−$0.9−$0.5−$0.5−$0.7−$0.9−$0.4−$1.3−$1.2
−$0.41−$0.20−$0.33−$0.45−$0.59−$0.28−$0.83−$0.78
2.32.31.51.51.51.51.51.5

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.